Vitura Health Ltd

VIT · AU · Healthcare / Drug Manufacturers - Specialty & Generic

0.019AUD-0.00 (-5.00%)

Price History

Full chart

Market Stats

Previous Close0.02

Open0.019

Day Range0.019 – 0.019

52-Week Range0.018 – 0.071

Volume20.85K

Market Cap12.59M

P/E (TTM)0.00

Forward P/E0.00

EPS-0.01

Dividend Yield0.00%

Beta-1.14

50-Day Avg0.023

200-Day Avg0.0365

About

Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia. It operates through two segments: Sales and Distribution; and Clinics and Services. The company operates CanView, an online platform that delivers prescribing, dispensing, and medication management solutions for alternative therapies; Doctors on Demand, a premier provider of on-demand virtual healthcare services; BHC, an alternative therapy distributor; CDA Clinics, which provides medicinal consultations and prescription services; and Cannadoc, a therapy clinic that offers telehealth consultations. It also offers psychedelics under the Cortexa brand; Adaya, which provides hybrid formulations and Australian-cultivated products; Candor Medical, that provides care to patients; and inscape, which offers crafted formulations for individual needs. In addition, the company engages in the supply of MDMA and synthetic psilocybin for therapeutic purposes. The company was formerly known as Cronos Australia Limited and changed its name to Vitura Health Limited in February 2023. Vitura Health Limited was incorporated in 2018 and is based in South Yarra, Australia.

Company Details

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Justin D. James
Employees0
HeadquartersSuite 21, Level 3, South Yarra, VIC, Australia, 3141, Australia
Websitehttps://www.vitura.com.au

Leadership

Mr. Justin D. JamesChief Executive Officer
Mr. Thomas Godfrey Howitt ACIS, AICPA, B.Com., C.A, FTIAInterim Chief Financial Officer · b. 1964

Financials

Income Statement

Currency: AUD	2017-06-30	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30	2024-06-30	2025-06-30	2026-06-30
Total Revenue	18.00K	447.59K	-	123.85K	21.71M	66.99M	117.34M	123.87M	124.04M	131.16M
Growth (%)	-	+2386.63%	-	-	+17431.02%	+208.54%	+75.16%	+5.56%	+0.13%	+5.74%
Cost of Revenue	-	9.50K	27.42K	7.06K	819.91K	41.56M	91.39M	89.65M	90.29M	127.23M
Gross Profit	18.00K	438.10K	-27.42K	116.79K	3.19M	25.43M	25.96M	34.22M	33.75M	3.92M
Gross Margin	100.00%	97.88%	-	94.30%	14.68%	37.96%	22.12%	27.63%	27.21%	2.99%
Operating Expense	40.34K	693.75K	2.86M	3.94M	1.49M	15.51M	6.09M	29.35M	28.51M	5.94M
Operating Income	-22.34K	-255.66K	-2.89M	-3.83M	1.70M	9.92M	19.86M	4.87M	5.24M	-2.01M
Operating Margin	-124.11%	-57.12%	-	-3088.86%	7.83%	14.81%	16.93%	3.93%	4.23%	-1.53%
EBITDA	62.66K	201.43K	-2.86M	-3.74M	2.12M	10.87M	21.08M	7.08M	5.64M	1.20M
EBITDA Margin	348.11%	45.00%	-	-3022.64%	9.77%	16.23%	17.96%	5.71%	4.55%	0.92%
Net Income	-22.34K	150.35K	-2.91M	-3.94M	-4.05M	6.05M	13.81M	3.51M	3.32M	-4.39M
Net Income Margin	-124.12%	33.59%	-	-3179.02%	-18.65%	9.03%	11.77%	2.84%	2.68%	-3.35%
Interest Expense	-	-	125.74K	205.14K	294.16K	441.44K	225.48K	1.05M	1.33M	1.70M
Interest Expense % of Total Revenue	-	-	-	165.63%	1.35%	0.66%	0.19%	0.85%	1.07%	1.30%

Balance Sheet

Currency: AUD	2017-06-30	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30	2024-06-30	2025-06-30	2026-06-30
Total Assets	1.22K	308.43K	17.96M	16.23M	12.69M	42.87M	46.90M	71.28M	75.49M	76.74M
Total Liabilities	23.44K	240.96K	3.75M	2.73M	3.47M	16.79M	11.99M	32.84M	27.89M	33.80M
Total Equity	-22.22K	67.47K	14.22M	13.44M	9.30M	26.10M	34.98M	38.78M	48.20M	43.55M
Cash	348	58.70K	17.61M	14.69M	9.47M	16.08M	18.85M	11.35M	7.58M	5.35M
Total Debt	20.69K	115.77K	2.20M	2.21M	2.65M	5.06M	1.71M	11.02M	11.97M	16.40M
Net Debt	20.34K	57.07K	-15.40M	-12.48M	-7.10M	-11.02M	-17.14M	-326.07K	4.39M	11.05M

Cash Flow

Currency: AUD	2017-06-30	2018-06-30	2019-06-30	2020-06-30	2021-06-30	2022-06-30	2023-06-30	2024-06-30	2025-06-30	2026-06-30
Operating Cash Flow	-20.46K	253.35K	-1.66M	-4.89M	1.07M	13.50M	9.71M	7.00M	2.67M	-91.02K
Investing Cash Flow	73.00K	-104.24K	66.14K	-515.91K	-160.69K	2.00M	-837.72K	-13.20M	-13.87M	-3.74M
Financing Cash Flow	20.81K	-94.26K	1.69M	19.93M	-262.03K	-1.50M	-6.10M	-1.30M	7.43M	1.60M
Capital Expenditure	0	104.24K	7.18K	269.40K	60.19K	376.84K	928.36K	786.35K	83.51K	125.78K
Free Cash Flow	-20.46K	149.11K	-1.66M	-5.16M	1.01M	13.13M	8.78M	6.21M	2.58M	-216.80K
Dividends Paid	-	-	-	19.92M	335.49K	1.50M	5.46M	5.44M	0	1.29M
FCF to OCF	100.00%	58.85%	100.43%	105.51%	94.36%	97.21%	90.44%	88.76%	96.87%	238.18%
Dividend Paid to FCF	-	-	-	-386.12%	33.29%	11.45%	62.22%	87.56%	0.00%	-596.65%

Earnings

Report Date	Feb 21, 2020	Aug 28, 2020	Feb 24, 2021	Aug 27, 2021	Feb 25, 2022	Aug 28, 2022	Feb 15, 2023	Feb 25, 2025	Aug 24, 2025
EPS Estimate	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EPS Actual	-0.03	-0.01	-0.02	-0.02	0.01	0.00	0.01	0.00	0.00
Surprise	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	Pre-market	-	-

Key Statistics & Ratios

Market Cap12.59M

Enterprise Value24.30M

Trailing P/E0.00

Forward P/E0.00

Price / Sales0.10

Price / Book0.32

EPS-0.01

Book Value0.066

Revenue (TTM)131.16M

Gross Profit (TTM)28.45M

EBITDA-1.69M

Profit Margin-3.35%

Operating Margin-3.09%

Return on Equity-9.73%

Return on Assets-1.65%

Shares Outstanding662.74M

Shares Float231.89M

Beta-1.14

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio153.85%

Dividends

20251×

0.00Sep 5, 2025

20231×

0.01Sep 4, 2023

20221×

0.01Sep 16, 2022